UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control
Brain molecule reverses movement deficits of Parkinson’s, offering new therapeutic target
October 04, 2024
KEYWORD
Parkinson’s disease
UCI launches Center for Neurotherapeutics to facilitate drug discovery and therapy delivery
UCI has launched a Center for Neurotherapeutics to facilitate drug discovery for neurological diseases. It’s led by Dr. Albert LaSpada, Distinguished Professor of pathology, neurology and biological chemistry, as well as associate dean for research development at the UCI School of Medicine; and Robert Spitale, professor and associate dean of research at the UCI School […]
October 18, 2022
UCI study could explain why Parkinson’s drug improves, then diminishes quality of life
L-dopa-protein complex may cause cellular iron overload in brain, leading to side effects
January 19, 2022